PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Work
Year: 2016
Type: review
Abstract: Immune checkpoint inhibition represents a major recent breakthrough in the treatment of malignant diseases including breast cancer. Blocking the programmed death receptor-1 (PD-1) and its ligand, PD-L... more
Source: Breast Care
Authors Andreas D. Hartkopf, Florin‐Andrei Taran, Markus Wallwiener, Christina B. Walter, Bernhard Krämer +2 more
Institutions University of Tübingen, Heidelberg University
Cites: 71
Cited by: 30,240
Related to: 10
FWCI: 453.6
Citation percentile (by year/subfield): 99.95
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze